Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources
Home/Rare Diseases/Vascular Ehlers-Danlos Syndrome

Connective Tissue & Musculoskeletal

Vascular Ehlers-Danlos Syndrome Clinical Trials

Also called vEDS, Ehlers-Danlos Type IV, EDS Type IV, Arterial-Ecchymotic Ehlers-Danlos Syndrome

Vascular Ehlers-Danlos Syndrome is a genetic connective tissue disorder caused by mutations in the COL3A1 gene, which affects the production of type III collagen. This protein is essential for maintaining the strength and elasticity of blood vessels, internal organs, and skin. People with vEDS have extremely fragile arteries and hollow organs that can rupture or dissect with minimal provocation, sometimes even from normal activities.

Vascular EDS is 1 of at least 13 types of Ehlers-Danlos syndrome, and the main EDS page covers the other types and their trials. Ehlers-Danlos syndrome, all types

In plain words, vascular Ehlers-Danlos syndrome is a genetic disorder where a gene change weakens collagen, a protein that keeps blood vessels and organs strong. Arteries, internal organs and skin become thin and fragile, so they can tear or bruise more easily.

Get an email when new Vascular Ehlers-Danlos Syndrome trials open or the FDA decides. Get alerts

Vascular Ehlers-Danlos Syndrome

Where treatments stand, from ClinicalTrials.gov and FDA labels

Also 5 studies with no phase, like observational studies.

FDA review0

No decision pending. FDA calendar

FDA-approved medicines0

No medicine's current FDA label names Vascular Ehlers-Danlos Syndrome yet.

Vascular Ehlers-Danlos Syndrome has no FDA-approved medicines, 6 open or active clinical trials (5 recruiting), and no pending FDA decision.

Labels checked October 21, 2026.Download the data

Latest for Vascular Ehlers-Danlos Syndrome

See all trialsThe week in rare disease

Each date is the day a change was posted. Open an item to see where things stand now.

More about Vascular Ehlers-Danlos Syndrome

The condition presents differently at different ages. Children often show minor features like joint hypermobility, easy bruising, and thin skin. Adults typically present with serious vascular emergencies as their first symptoms. The most common life-threatening complications are arterial ruptures (most often in the chest or abdomen), gastrointestinal perforations, and uterine ruptures during pregnancy.

Keep reading about Vascular Ehlers-Danlos Syndrome

Diagnosis requires genetic testing to identify pathogenic variants in the COL3A1 gene. While there is no cure, management focuses on regular monitoring with imaging studies, medication to reduce stress on blood vessels, activity restrictions, and careful planning for pregnancies.

What are the symptoms of Vascular Ehlers-Danlos Syndrome?

These are common symptoms of Vascular Ehlers-Danlos Syndrome, and how strong they are varies from person to person.

  • Thin, translucent skin with visible veins
  • Easy bruising and early-onset varicose veins
  • Distinctive facial features: thin lips, small chin, large eyes, narrow nose
  • Arterial ruptures, dissection, and aneurysms
  • Gastrointestinal perforation
  • Premature aging appearance of skin and joints

Who gets Vascular Ehlers-Danlos Syndrome?

Vascular EDS can affect people of any age and gender. About 25% experience life-threatening complications before age 20, and 80% by age 40. The condition is autosomal dominant, meaning only one affected gene copy from either parent is needed to cause the disease. Median survival is approximately 50 years.

Next steps: find trials you might fitsee what is being testedget help payingget alerts

Which new Vascular Ehlers-Danlos Syndrome medicines are in trials?

Investigational medicines Trial Friend tracks for Vascular Ehlers-Danlos Syndrome, with trial results, safety findings and where each one stands.

Side effects people have reported to the FDA

Side effects people have reported to the FDA

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Diagnosis and genetic testing

Genetic testing for Vascular Ehlers-Danlos Syndrome

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Vascular Ehlers-Danlos Syndrome resources

Reputable organizations and medical references for learning more about Vascular Ehlers-Danlos Syndrome, including disease registries, foundation resources, and clinical guidelines.

Active clinical trials for Vascular Ehlers-Danlos Syndrome

Use this Vascular Ehlers-Danlos Syndrome clinical trial finder to see the 5 studies recruiting patients and 1 not yet recruiting in the United States and worldwide, with eligibility criteria in plain English. Of these, 3 test a treatment and 3 are observational studies or registries; each card says which. Every trial comes from ClinicalTrials.gov.

Jump to the trial list, the site map or the pipeline timeline.

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

6 active trials worldwide
Filter:
Sort:
RecruitingObservational study, no treatment givenRecently updatedNCT07516496

Metabolic Phenotyping in vEDS

Intervention: No intervention, observational

Sponsor: Cambridge University Hospitals NHS Foundation Trust

This research study will investigate whether participants with vascular Ehlers-Danlos syndrome (vEDS), a rare inherited condition, have problems with the way the participants' body stores and uses fat (adipose tissue). vEDS is caused by changes in a gene called COL3A1, which make...

Ages 18 Years to 85 Years1 location
Started Mar 2026Updated 3 weeks agoEst. Mar 2030 (~3y 3m)
RecruitingObservational study, no treatment givenUpdated a few months agoNCT07672210

PregnAncy-Related Aortic DISsEction in China

Intervention: Intervention strategies including medication or surgery

Sponsor: DeltaHealth Hospital · Shanghai

A multicenter observational study on pregnancy-related aortic dissection

Ages 16 Years to 55 Years4 locations
Started Mar 2026Updated 4 months agoEst. Nov 2026
Not yet recruitingTreatment trialUpdated a few months agoNCT07697573

An Exercise and Lifestyle Programme for Adults With Vascular Ehlers-Danlos Syndrome: A Feasibility Study

Intervention: Co-designed exercise-based lifestyle intervention

Sponsor: Sheffield Hallam University

Vascular Ehlers-Danlos syndrome (vEDS) is a rare, life-threatening connective tissue disorder. People with vEDS have often been advised to limit physical activity, yet the safety and feasibility of structured exercise in this group is poorly understood. This study works with peop...

Ages 18 Years+1 location
Expected to start Mar 2027Updated 4 months agoEst. Oct 2027 (~10 months)
RecruitingObservational study, no treatment givenNo updates in a whileNCT06546137

National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

Intervention: whole genome sequencing

Sponsor: Hospital do Coracao

The goal of this observational study is to develop a registry of Brazilian patients with hereditary cardiovascular diseases, combining clinical and genomic data. The main questions it aims to answer are:

Ages not specified
Started Apr 2025Updated 6 months agoEst. Aug 2026
RecruitingTreatment trialPhase 3Hasn't posted an update in over a yearNCT05432466

Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome

Intervention: ACER-002 (celiprolol) 200 mg BID, Placebo BID

Sponsor: Acer Therapeutics Inc.

This is a prospective, Phase 3, randomized, double-blind, placebo-controlled efficacy study to evaluate celiprolol in patients genetically confirmed as COL3A1-positive vEDS using a decentralized clinical trial design.

Ages 15 Years to 64 Years1 location
Started Nov 2022Updated 1 year agoEst. Mar 2029 (~2y 3m)
Find Vascular Ehlers-Danlos Syndrome trials near you, ranked by distance →
Active trial locations2 cities in the US
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.

Trial Pipeline

Nov 2022 to Apr 2031
2023
2025
2027
2029
2031
now
Phase 3
Observational
Observational
RecruitingNot yet recruitingDelayed startTodayHover a bar for trial details

Read more about Vascular Ehlers-Danlos Syndrome trials

Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Vascular Ehlers-Danlos Syndrome foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Vascular Ehlers-Danlos Syndrome patient communities

Facebook groups, Reddit communities and YouTube channels where Vascular Ehlers-Danlos Syndrome patients, caregivers and advocacy groups talk.

Companies developing Vascular Ehlers-Danlos Syndrome treatments

Drugmakers that list Vascular Ehlers-Danlos Syndrome in their rare disease portfolio, 1 in all.

Questions people ask about Vascular Ehlers-Danlos Syndrome